DeutschNewstral
Article
Mmarketwatch.com on 2017-05-18 15:30
Biogen has acquired Remedy Pharma's stroke medication for $120 mln
Related news
- MFDA Approves Biogen, Eisai Remedy Lecanemabmvtelegraph.com
Big Pharma's Biogen Dilemmawsj.com- MPTC Therapeutics will buy Marathon Pharma's controversial DMD drug for $75 mln cash, $65 million in PTC stockmarketwatch.com
AI: Pharma's Perfect MedicineForbes- Biogen Spin-Off Bioverativ To Be AcquiredForbes
Analysts high on ZS Pharma's agreement to be acquired by AstraZenecabizjournals.com
CMS Issues Proposed Remedy for 340B-Acquired Drug Payment Policyjdsupra.com
Big pharma's cash flood is drowning seniorsCNN- BiogenForbes
Biogen tops Street 3Q forecastsdothaneagle.com- MGW Pharma's cannabis-derived drug to be reviewed by FDAmarketwatch.com
Biogen beats 2Q profit forecastswkrg.com
Trump administration spent $21 million to test heartburn medication as coronavirus remedybangordailynews.com- BAs Washington Ties Pharma's Hands, China Is Leaping Ahead4 minbarrons.com
- MBiogen reports Q1 profit beat, sales missmarketwatch.com
- MBiogen earnings and revenue rise, beat expectationsmarketwatch.com
- Policy Update - CMS Finalizes Remedy for 340B-Acquired Drugs Purchased in CYs 2018–2022jdsupra.com
Store medication safelynwasianweekly.com- CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022jdsupra.com